Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, February 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 68 articles:
HTML format


 

Single Articles

  1. HAYES B, Burgell R, Apputhurai P, Garg M, et al
    Extending the Common Sense Model to Explore the Impact of Visceral Sensitivity on Quality of Life in Inflammatory Bowel Disease.
    Turk J Gastroenterol. 2022 Feb 4. doi: 10.5152/tjg.2021.201158.
    PubMed    
    Abstract available

  2. WANG Z, Xu M, Shi Z, Bao C, et al
    Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial.
    J Ethnopharmacol. 2022 Jan 31:115064. doi: 10.1016/j.jep.2022.115064.
    PubMed    
    Abstract available

  3. YILMAZ A, Gokcen P, Yilmaz H, Huzmeli C, et al
    Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening.
    Eurasian J Med. 2021;53:220-226.
    PubMed    
    Abstract available

  4. FATAHI S, Hosseini A, Sohouli MH, Sayyari A, et al
    Effects of probiotic supplementation on abdominal pain severity in pediatric patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials.
    World J Pediatr. 2022 Feb 1. pii: 10.1007/s12519-022-00516.
    PubMed    
    Abstract available

  5. COONEY J, Appiahene P, Findlay R, Al-Hillawi L, et al
    COVID-19 infection causing residual gastrointestinal symptoms - a single UK centre case series.
    Clin Med (Lond). 2022 Feb 1. pii: clinmed.2021-0522.
    PubMed    
    Abstract available

  6. BARANDOUZI ZA, Lee J, Del Carmen Rosas M, Chen J, et al
    Associations of neurotransmitters and the gut microbiome with emotional distress in mixed type of irritable bowel syndrome.
    Sci Rep. 2022;12:1648.
    PubMed    
    Abstract available

  7. NURKO S, Saps M, Kossovsky J, Zion SR, et al
    Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial.
    JAMA Pediatr. 2022 Jan 31. pii: 2788489. doi: 10.1001/jamapediatrics.2021.5750.
    PubMed    
    Abstract available

  8. YANG Q, Wei ZC, Liu N, Pan YL, et al
    Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study.
    World J Clin Cases. 2022;10:563-575.
    PubMed    
    Abstract available

  9. LENDERS M, Brand E
    Fabry disease - a multisystemic disease with gastrointestinal manifestations.
    Gut Microbes. 2022;14:2027852.
    PubMed    
    Abstract available

  10. MAEVA M, Elodie B, Nathalie R, Manon D, et al
    AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.
    Gut Microbes. 2022;14:2022997.
    PubMed    
    Abstract available

  11. SINGH R, Zogg H, Ghoshal UC, Ro S, et al
    Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
    Front Pharmacol. 2022;13:808195.
    PubMed    
    Abstract available

  12. SERRA J
    Management of bloating.
    Neurogastroenterol Motil. 2022 Feb 10:e14333. doi: 10.1111/nmo.14333.
    PubMed    
    Abstract available

  13. BISCHOFF SC
    [Food sensitivities of the digestive tract-Part 2: Food intolerances].
    Internist (Berl). 2022 Feb 9. pii: 10.1007/s00108-021-01257.
    PubMed    
    Abstract available

  14. GEORGESCU D, Caraba A, Ionita I, Lascu A, et al
    Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome.
    Int J Womens Health. 2022;14:41-56.
    PubMed    
    Abstract available

  15. TAKAKURA W, Kudaravalli P, Chatterjee C, Pimentel M, et al
    Campylobacter infection and the link with Irritable Bowel Syndrome: on the pathway towards a causal association.
    Pathog Dis. 2022 Feb 3. pii: 6521441. doi: 10.1093.
    PubMed    
    Abstract available

  16. WEBER HC
    Irritable bowel syndrome and diet.
    Curr Opin Endocrinol Diabetes Obes. 2022 Feb 7. pii: 01266029-900000000-99136.
    PubMed    
    Abstract available

  17. HILLESTAD EMR, van der Meeren A, Nagaraja BH, Bjorsvik BR, et al
    Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome.
    World J Gastroenterol. 2022;28:412-431.
    PubMed    
    Abstract available

  18. LOOSEN SH, Kostev K, Jordens MS, Luedde T, et al
    Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany.
    BMC Gastroenterol. 2022;22:48.
    PubMed    
    Abstract available

  19. SHAH A, Fairlie T, Brown G, Jones MP, et al
    Duodenal Eosinophils and Mast Cells in Functional dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Clin Gastroenterol Hepatol. 2022 Feb 2. pii: S1542-3565(22)00068.
    PubMed    
    Abstract available

  20. SAYUK GS, Tack J
    TEGASEROD: WHAT'S OLD IS NEW AGAIN.
    Clin Gastroenterol Hepatol. 2022 Feb 2. pii: S1542-3565(22)00078.
    PubMed    
    Abstract available

  21. ISPIRYAN L, Zannini E, Arendt EK
    FODMAP modulation as a dietary therapy for IBS: Scientific and market perspective.
    Compr Rev Food Sci Food Saf. 2022 Feb 4. doi: 10.1111/1541-4337.12903.
    PubMed    
    Abstract available

  22. POON D, Law GR, Major G, Andreyev HJN, et al
    A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome.
    Sci Rep. 2022;12:1949.
    PubMed    
    Abstract available

  23. HAAS JW, Ongaro G, Jacobson E, Conboy LA, et al
    Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study.
    BMC Psychol. 2022;10:20.
    PubMed    
    Abstract available

  24. GEMCIOGLU E, Yilmaz Cakmak N, Baser S, Kocaoz S, et al
    Factors affecting the use of herbal products in patients with Irritable Bowel Syndrome and their results: case-control study.
    BMC Gastroenterol. 2022;22:43.
    PubMed    
    Abstract available

  25. HUJOEL IA, Hujoel MLA
    The Role of Copper and Zinc in Irritable Bowel Syndrome: A Mendelian Randomization Study.
    Am J Epidemiol. 2022;191:85-92.
    PubMed    
    Abstract available

  26. KASSAM N, Aziz O, Aghan E, Mandwa M, et al
    Severe Crohn's Disease With Intra-abdominal Fistula: First Reported Case From Tanzania.
    Cureus. 2022;14:e21277.
    PubMed    
    Abstract available

  27. GOEBEL-STENGEL M, Lohmiller J, Schaffeler N, Zipfel S, et al
    [Impact of the COVID pandemic on the anxiety of patients with functional gastrointestinal symptoms].
    Z Gastroenterol. 2022 Feb 17. doi: 10.1055/a-1749-6469.
    PubMed    
    Abstract available

  28. SANDLER RS, Hansen JJ, Peery AF, Woosley JT, et al
    Intraepithelial and lamina propria lymphocytes do not correlate with symptoms or exposures in microscopic colitis.
    Clin Transl Gastroenterol. 2022 Feb 10. pii: 01720094-990000000-00024.
    PubMed    
    Abstract available

  29. FUCHS CD, Trauner M
    Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.
    Nat Rev Gastroenterol Hepatol. 2022 Feb 14. pii: 10.1038/s41575-021-00566.
    PubMed    
    Abstract available

  30. ORLANDO A, Chimienti G, Notarnicola M, Russo F, et al
    The Ketogenic Diet Improves Gut-Brain Axis in a Rat Model of Irritable Bowel Syndrome: Impact on 5-HT and BDNF Systems.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  31. SETTEMBRE C, D'Antonio E, Moscato P, Loi G, et al
    Association among Disorders of Gut-Brain Interaction (DGBI) and Fibromyalgia: A Prospective Study.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  32. LI J, Xu K, Guo Y, Chen X, et al
    Case evidence of repetitive transcranial magnetic stimulation in the management of refractory irritable bowel syndrome with comorbid depression.
    Brain Stimul. 2022 Feb 11. pii: S1935-861X(22)00026.
    PubMed    


  33. FUKUDO S, Kano M, Sato Y, Muratsubaki T, et al
    Histamine Neuroimaging in Stress-Related Disorders.
    Curr Top Behav Neurosci. 2022 Feb 14. doi: 10.1007/7854_2021.
    PubMed    
    Abstract available

  34. TAO E, Long G, Yang T, Chen B, et al
    Maternal Separation Induced Visceral Hypersensitivity Evaluated via Novel and Small Size Distention Balloon in Post-weaning Mice.
    Front Neurosci. 2022;15:803957.
    PubMed    
    Abstract available

  35. ZHANG B, Shi H, Cao S, Xie L, et al
    Revealing the magic of acupuncture based on biological mechanisms: A literature review.
    Biosci Trends. 2022 Feb 10. doi: 10.5582/bst.2022.01039.
    PubMed    
    Abstract available

  36. QI LY, Li HP, Yang NN, Li YJ, et al
    [Research progress on mechanism of acupuncture and moxibustion in treatment of irritable bowel syndrome].
    Zhongguo Zhen Jiu. 2022;42:231-6.
    PubMed    
    Abstract available

  37. WANG JJ, Chu HR, Wu LB
    [CHU Hao-ran's experience in treatment of diarrhea-predominant irritable bowel syndrome with acupuncture and moxibustion].
    Zhongguo Zhen Jiu. 2022;42:187-90.
    PubMed    
    Abstract available

  38. BURKI TK
    Modifying Rome IV for clinical practice.
    Lancet Gastroenterol Hepatol. 2022;7:116.
    PubMed    
    Abstract available

  39. ZHAO T, Zhang Y, Lee J, Starkweather AR, et al
    The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  40. DANILUK J, Malecka-Wojciesko E, Skrzydlo-Radomanska B, Rydzewska G, et al
    The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome-A Systematic Review.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  41. KIM JH, Baek HS, Ha EK, Cha HR, et al
    Association of Consuming Tap Water or Purified Water during Infancy with Irritable Bowel Syndrome in Children.
    Children (Basel). 2022;9.
    PubMed    
    Abstract available

  42. LACY BE, Cangemi DJ, Wise JL, Crowell MD, et al
    Development and validation of a novel scoring system for bloating and distension: The Mayo Bloating Questionnaire.
    Neurogastroenterol Motil. 2022 Feb 24:e14330. doi: 10.1111/nmo.14330.
    PubMed    
    Abstract available

  43. BHANDARI A, Chaudhary A
    Low Vitamin D Levels in Patients with Irritable Bowel Syndrome of a Tertiary Care Hospital: A Descriptive Cross-sectional Study.
    JNMA J Nepal Med Assoc. 2021;59:1030-1034.
    PubMed    
    Abstract available

  44. DARIPA B, Kumar A
    A Case Report of Rare Presentation and Delay in the Diagnosis of Neuropathic Abdominal Pain Secondary to Asymptomatic Pott's Spine in Elderly Patients.
    Cureus. 2022;14:e21399.
    PubMed    
    Abstract available

  45. DONNET AS, Hasan SS, Whorwell PJ
    Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.
    Therap Adv Gastroenterol. 2022;15:17562848221074208.
    PubMed    
    Abstract available

  46. ZHAO Y, Jiang HL, Shi Y, Zhang W, et al
    Electroacupuncture Alleviates Visceral Hypersensitivity in IBS-D Rats by Inhibiting EGCs Activity through Regulating BDNF/TrkB Signaling Pathway.
    Evid Based Complement Alternat Med. 2022;2022:2497430.
    PubMed    
    Abstract available

  47. DAI YX, Tai YH, Chang YT, Chen TJ, et al
    Bidirectional association between alopecia areata and irritable bowel syndrome: A nationwide population-based cohort study.
    Australas J Dermatol. 2022 Feb 23. doi: 10.1111/ajd.13809.
    PubMed    
    Abstract available

  48. NISTICO V, Rossi RE, D'Arrigo AM, Priori A, et al
    Functional neuroimaging in Irritable Bowel Syndrome: a systematic review highlights common brain alterations with Functional Movement Disorders.
    J Neurogastroenterol Motil. 2022 Feb 22. pii: jnm21079. doi: 10.5056/jnm21079.
    PubMed    
    Abstract available

  49. NOZU T, Okumura T
    Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor-Toll-like Receptor 4-Proinflammatory Cytokine Signaling.
    J Neurogastroenterol Motil. 2022 Feb 22. pii: jnm21002. doi: 10.5056/jnm21002.
    PubMed    
    Abstract available

  50. QUIGLEY E
    Clinical trials of probiotics in patients with IBS - some points to consider.
    J Neurogastroenterol Motil. 2022 Feb 22. pii: jnm22012. doi: 10.5056/jnm22012.
    PubMed    
    Abstract available

  51. PENG Z, Tang J
    Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier.
    Front Microbiol. 2022;12:783010.
    PubMed    
    Abstract available

  52. ZHANG L, Wang R, Chen Y, Yang P, et al
    EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome.
    Life Sci. 2022;295:120419.
    PubMed    
    Abstract available

  53. FRANDEMARK A, Tornblom H, Simren M, Jakobsson S, et al
    Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome.
    BMC Gastroenterol. 2022;22:73.
    PubMed    
    Abstract available

  54. SAMY W, El Gebaly A, Ahmed NH, Talaat A, et al
    Ghrelin polymorphism/TRPV1 receptor expression in Egyptian IBS patients.
    Cytokine. 2022;152:155827.
    PubMed    
    Abstract available

  55. STURKENBOOM R, Keszthelyi D, Masclee AAM, Essers BAB, et al
    Discrete choice experiment reveals strong preference for dietary treatment among patients with irritable bowel syndrome.
    Clin Gastroenterol Hepatol. 2022 Feb 15. pii: S1542-3565(22)00142.
    PubMed    
    Abstract available

  56. WU J, Masuy I, Biesiekierski JR, Fitzke HE, et al
    Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Feb 15. doi: 10.1111/apt.16812.
    PubMed    
    Abstract available

  57. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Feb 15. doi: 10.1111/apt.16816.
    PubMed    
    Abstract available

  58. KIKUCHI S, Oe Y, Ito Y, Sozu T, et al
    Group cognitive behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial.
    Am J Gastroenterol. 2022 Jan 29. pii: 00000434-990000000-00236.
    PubMed    
    Abstract available

  59. WU S, Yuan C, Liu S, Zhang Q, et al
    Irritable bowel syndrome and long-term risk of cancer: a prospective cohort study among 0.5 million adults in UK Biobank.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00239.
    PubMed    
    Abstract available

  60. VIJAYVARGIYA P, Breen-Lyles M, Nord SL, Maselli D, et al
    Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-022-07379.
    PubMed    
    Abstract available

  61. LIU H, Zou Y, Kan Y, Li X, et al
    Prevalence and Influencing Factors of Irritable Bowel Syndrome in Medical Staff: A Meta-Analysis.
    Dig Dis Sci. 2022 Feb 17. pii: 10.1007/s10620-022-07401.
    PubMed    
    Abstract available

  62. ELHUSEIN AM, Fadlalmola HA
    Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients: An Updated Systematic Review and Meta-Analysis.
    Gastroenterol Nurs. 2022;45:11-20.
    PubMed    
    Abstract available

  63. GAO J, Xiong T, Grabauskas G, Owyang C, et al
    Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell-prostaglandin E2.
    Gastroenterology. 2022 Feb 12. pii: S0016-5085(22)00144.
    PubMed    
    Abstract available

  64. MUSTAFA U, Ghoshal UC
    The challenges of implementing low fermentable oligo-, di-, mono-saccharides and polyol diet in India: An analysis of available data.
    Indian J Gastroenterol. 2022 Feb 24. pii: 10.1007/s12664-022-01250.
    PubMed    
    Abstract available

  65. FENG HY, Chan CH, Chu YC, Qu XM, et al
    Patients with ankylosing spondylitis have high risk of irritable bowel syndrome. A long-term nationwide population-based cohort study.
    Postgrad Med. 2022 Feb 9. doi: 10.1080/00325481.2022.2041338.
    PubMed    
    Abstract available

  66. JOHANSEN SG, Ness-Jensen E
    The changes in prevalence and risk of irritable bowel syndrome over time in a population-based cohort, the HUNT study, Norway.
    Scand J Gastroenterol. 2022 Feb 4:1-7. doi: 10.1080/00365521.2022.2028005.
    PubMed    
    Abstract available

  67. RUDERSTAM H, Ohlsson B
    Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases.
    Scand J Gastroenterol. 2022 Feb 1:1-11. doi: 10.1080/00365521.2022.2031281.
    PubMed    
    Abstract available

  68. MAZZAWI T, Hausken T, El-Salhy M
    Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
    Scand J Gastroenterol. 2022 Feb 14:1-5. doi: 10.1080/00365521.2022.2036809.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;